Anuradha Chougule

1.5k total citations
53 papers, 620 citations indexed

About

Anuradha Chougule is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Anuradha Chougule has authored 53 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Anuradha Chougule's work include Lung Cancer Treatments and Mutations (40 papers), Lung Cancer Diagnosis and Treatment (19 papers) and Lung Cancer Research Studies (14 papers). Anuradha Chougule is often cited by papers focused on Lung Cancer Treatments and Mutations (40 papers), Lung Cancer Diagnosis and Treatment (19 papers) and Lung Cancer Research Studies (14 papers). Anuradha Chougule collaborates with scholars based in India, United States and France. Anuradha Chougule's co-authors include Kumar Prabhash, Vanita Noronha, Amit Joshi, Vijay Patil, Abhishek Mahajan, Amit Janu, Pratik Chandrani, Amit Dutt, Rajiv Kumar and Saral Desai and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anuradha Chougule

50 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anuradha Chougule India 13 481 357 162 142 52 53 620
Frédéric Dugay France 15 508 1.1× 291 0.8× 202 1.2× 319 2.2× 72 1.4× 25 723
Irene De Santo Italy 9 342 0.7× 394 1.1× 213 1.3× 169 1.2× 35 0.7× 13 692
Daniela Morales-Espinosa Spain 12 190 0.4× 276 0.8× 155 1.0× 206 1.5× 30 0.6× 25 534
Yongkui Lu China 11 259 0.5× 350 1.0× 145 0.9× 220 1.5× 92 1.8× 20 657
Andri Papakonstantinou Sweden 11 198 0.4× 237 0.7× 151 0.9× 87 0.6× 36 0.7× 33 419
Nuria Kotecki Belgium 13 284 0.6× 324 0.9× 66 0.4× 137 1.0× 59 1.1× 68 592
Raffaele Ratta Italy 17 435 0.9× 327 0.9× 185 1.1× 197 1.4× 82 1.6× 65 602
Emily K. Slotkin United States 13 271 0.6× 213 0.6× 135 0.8× 230 1.6× 26 0.5× 38 548
Xiaohong Yan United States 13 157 0.3× 364 1.0× 109 0.7× 233 1.6× 91 1.8× 50 610
Peijian Peng China 14 385 0.8× 558 1.6× 152 0.9× 183 1.3× 102 2.0× 26 834

Countries citing papers authored by Anuradha Chougule

Since Specialization
Citations

This map shows the geographic impact of Anuradha Chougule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anuradha Chougule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anuradha Chougule more than expected).

Fields of papers citing papers by Anuradha Chougule

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anuradha Chougule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anuradha Chougule. The network helps show where Anuradha Chougule may publish in the future.

Co-authorship network of co-authors of Anuradha Chougule

This figure shows the co-authorship network connecting the top 25 collaborators of Anuradha Chougule. A scholar is included among the top collaborators of Anuradha Chougule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anuradha Chougule. Anuradha Chougule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Amit, Akhil Kapoor, Vanita Noronha, et al.. (2024). Lorlatinib in the second line and beyond for ALK positive lung cancer: real-world data from resource-constrained settings. PubMed. 2(1). 35–35. 1 indexed citations
2.
Noronha, Vanita, Vijay Patil, Nandini Menon, et al.. (2024). Clinical characteristics, outcomes and prognostic factors in KRAS mutant lung cancers: experience from a tertiary care cancer center in India. ecancermedicalscience. 18. 1674–1674.
3.
Noronha, Vanita, Srikanth S. Manda, Rohit Mishra, et al.. (2023). Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy. Gene. 893. 147952–147952. 4 indexed citations
4.
Chougule, Anuradha, Pratik Chandrani, Vanita Noronha, et al.. (2023). Real-World Evidence of EGFR Targeted Therapy in NSCLC– A Brief Report of Decade Long Single Center Experience. JTO Clinical and Research Reports. 4(11). 100566–100566. 3 indexed citations
5.
Noronha, Vanita, Vijay Patil, Ajay Singh, et al.. (2022). NRAS mutation in differentiated thyroid cancer. Cancer Research Statistics and Treatment. 5(4). 722–727. 2 indexed citations
6.
Shetty, Omshree, Subhash Yadav, Rajiv Kumar, et al.. (2022). EGFR exon 20 insertion in non-small cell lung cancer. Cancer Research Statistics and Treatment. 5(1). 122–130. 1 indexed citations
7.
Noronha, Vanita, George John, Anuradha Chougule, et al.. (2022). Treatment pattern and outcomes in de novo T790M-mutated non-small cell lung cancer. ecancermedicalscience. 16. 1385–1385. 6 indexed citations
8.
Noronha, Vanita, Omshree Shetty, Asawari Patil, et al.. (2021). FGFR alterations in head-and-neck cancer. Cancer Research Statistics and Treatment. 4(4). 737–746. 3 indexed citations
9.
Abraham, George, Vanita Noronha, Amit Joshi, et al.. (2021). Rare case of Skene gland adenocarcinoma with RET-rearrangement. Cancer Research Statistics and Treatment. 4(1). 130–135. 3 indexed citations
10.
Noronha, Vanita, Vijay Patil, Nandini Menon, et al.. (2021). Systemic Therapy in Thyroid Cancer. Indian Journal of Surgical Oncology. 13(1). 68–80. 2 indexed citations
11.
Chougule, Anuradha, Vaishakhi Trivedi, Vichitra Behel, et al.. (2020). Concordance of epidermal growth factor receptor mutation detection in bodily fluids other than blood with tissue biopsy: A retrospective analysis. Cancer Research Statistics and Treatment. 3(3). 475–475. 6 indexed citations
12.
Joshi, Amit, Nikhil Pande, Vanita Noronha, et al.. (2019). ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes. ecancermedicalscience. 13. 900–900. 24 indexed citations
13.
Prabhash, Kumar, Vijay Patil, Anuradha Chougule, et al.. (2017). Efficacy of gefitinib in epidermal growth factor receptor-activating mutation-positive nonsmall cell lung cancer: Does exon 19 deletion differ from exon 21 mutation?. Lung India. 35(1). 27–27. 2 indexed citations
14.
Prabhash, Kumar, Saurabh Zanwar, Vanita Noronha, et al.. (2017). Efficacy of crizotinib in ALK mutant non-small cell lung cancers that are positive by IHC but negative by FISH compared to FISH positive cases. Indian Journal of Cancer. 54(4). 678–678. 5 indexed citations
15.
Talreja, Vikas, Vanita Noronha, Vijay Patil, et al.. (2017). P3.02b-055 Impact of Pemetrexed Chemotherapy in Exon 19 or Exon 21 Mutated NSCLC. Journal of Thoracic Oncology. 12(1). S1223–S1223. 1 indexed citations
16.
Zanwar, Saurabh, Vanita Noronha, Amit Joshi, et al.. (2017). Feasibility and outcome of repeat biopsy upon progression on tyrosine kinase inhibitors in patients with EGFR mutation positive adenocarcinoma of lung-an Indian tertiary cancer centre experience.. Journal of Clinical Oncology. 35(15_suppl). e20628–e20628. 1 indexed citations
17.
Pasquier, Eddy, Nicolás André, Janine Street, et al.. (2016). Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study. EBioMedicine. 6. 87–95. 86 indexed citations
18.
Noronha, Vanita, Amit Joshi, Anant Gokarn, et al.. (2014). The Importance of Brain Metastasis in EGFR Mutation Positive NSCLC Patients. PubMed. 2014. 1–4. 28 indexed citations
19.
Chougule, Anuradha, Kumar Prabhash, Vanita Noronha, et al.. (2013). Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian Ethnicity. PLoS ONE. 8(10). e76164–e76164. 89 indexed citations
20.
Nair, Chandrika N., et al.. (1995). Immunophenotype and Ultrastructural Studies in Blast Crisis of Chronic Myeloid Leukemia. Leukemia & lymphoma. 19(3-4). 309–313. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédéric Dugay Breakdown of academic impact, for papers by Irene De Santo Breakdown of academic impact, for papers by Daniela Morales-Espinosa Breakdown of academic impact, for papers by Yongkui Lu Breakdown of academic impact, for papers by Andri Papakonstantinou Breakdown of academic impact, for papers by Nuria Kotecki Breakdown of academic impact, for papers by Raffaele Ratta Breakdown of academic impact, for papers by Emily K. Slotkin Breakdown of academic impact, for papers by Xiaohong Yan Breakdown of academic impact, for papers by Peijian Peng
Rankless by CCL
2026